259
Listing date: | 14/12/2016 | |
Ticker: | GENT-ME |
Gentian is a Norway based, international company working on global solutions that change health care. With in-house production, R&D and marketing, Gentian serves the global market for diagnostic tests with sensitive biochemical products developed by leveraging proprietary, disruptive, diagnostic technologies. Current and pipeline products contribute to improved diagnostics and cost reductions in treatment of kidneys, inflammation, cardiovascular diseases, cancer and viral infections.
Quotes, details on the share and the company, notifications and historical prices
All new listings at Oslo Børs and Oslo Axess